Extract from the Register of European Patents

EP About this file: EP0749581

EP0749581 - BINDING ASSAY USING BINDING AGENTS WITH TAIL GROUPS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.10.1999
Database last updated on 21.03.2026
Most recent event   Tooltip08.10.1999No opposition filed within time limitpublished on 24.11.1999 [1999/47]
Applicant(s)For all designated states
Multilyte Limited
3rd floor, 63 Lincoln's Inn Fields
London WC2A 3LW / GB
[1996/52]
Inventor(s)01 / EKINS, Roger, P. Multilyte Limited
Uty. Clge and Mdsx School of Medicine, Mortimer St
London W1N 8AA / GB
[1996/52]
Representative(s)Armitage, Ian Michael, et al
Mewburn Ellis LLP
York House
23 Kingsway
London WC2B 6HP / GB
[N/P]
Former [1996/52]Armitage, Ian Michael, et al
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date95910661.810.03.1995
[1996/52]
WO1995GB00521
Priority number, dateGB1994000470911.03.1994         Original published format: GB 9404709
[1996/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9524649
Date:14.09.1995
Language:EN
[1995/39]
Type: A1 Application with search report 
No.:EP0749581
Date:27.12.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 14.09.1995 takes the place of the publication of the European patent application.
[1996/52]
Type: B1 Patent specification 
No.:EP0749581
Date:02.12.1998
Language:EN
[1998/49]
Search report(s)International search report - published on:EP14.09.1995
ClassificationIPC:G01N33/58, G01N33/532, G01N33/543, C12Q1/68
[1996/52]
CPC:
C12Q1/6804 (EP,US); C12Q1/6837 (EP,US); G01N33/532 (EP,US);
G01N33/54306 (EP,US); G01N33/54353 (EP,US); G01N33/58 (EP,US);
G01N2458/10 (EP,US) (-)
C-Set:
C12Q1/6804, C12Q2565/501 (EP,US);
C12Q1/6837, C12Q2563/131 (US,EP)
Designated contracting statesCH,   DE,   ES,   FR,   GB,   IT,   LI [1998/36]
Former [1996/52]AT,  BE,  CH,  DE,  DK,  ES,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:BINDUNGSTEST UNTER VERWENDUNG VON AGENZIEN MIT SCHWANZGRUPPEN[1996/52]
English:BINDING ASSAY USING BINDING AGENTS WITH TAIL GROUPS[1996/52]
French:TEST DE FIXATION A L'AIDE D'AGENTS DE FIXATION POSSEDANT DES GROUPES D'EXTREMITE[1996/52]
Entry into regional phase30.09.1996National basic fee paid 
30.09.1996Designation fee(s) paid 
30.09.1996Examination fee paid 
Examination procedure23.08.1995Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.09.1996Examination requested  [1996/52]
22.01.1998Despatch of communication of intention to grant (Approval: Yes)
27.05.1998Communication of intention to grant the patent
18.08.1998Fee for grant paid
18.08.1998Fee for publishing/printing paid
Opposition(s)03.09.1999No opposition filed within time limit [1999/47]
Fees paidRenewal fee
21.03.1997Renewal fee patent year 03
23.03.1998Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]   R.P. VISCIDI ET AL.: "MONOCLONAL ANTIBODY SOLUTION HYBRIDIZATION ASSAY FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS NUCLEIC ACIDS", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 27, no. 1, WASHINGTON DC USA, pages 120 - 125 [X] 1-3 * figure 1 *
 [A]   R. EKINS: "Immunoassays: current events in immunoanalysis", NUCLEAR MEDICINE AND BIOLOGY, vol. 21, no. 3, 1 March 1994 (1994-03-01), LONDON UK, pages 495 - 521 [A] 1-14 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.